Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Faecal flora of patients with ulcerative colitis during treatment with salicylazosulphapyridine.

× No keyword cloud information.

13 in total

1. Distribution and metabolism of salicyl-azo-sulfapyridine. II. A study with S35-salicyl-azo-sulfapyridine and S35-sulfapyridine.

Authors: A HANNGREN; E HANSSON; N SVARTZ; S ULLBERG
Journal: Acta Med Scand Date: 1963-04

2. Metabolic studies on azulfidine, azudimidine and one analogue.

Authors: L E BOTTIGER; H MOLLERBERG
Journal: Acta Med Scand Date: 1959-11-18

3. A critical analysis of the use of salicylazosulfapyridine in chronic ulcerative colitis.

Authors: C G MOERTEL; J A BARGEN
Journal: Ann Intern Med Date: 1959-11 Impact factor: 25.391

4. A comparative trial of salazopyrin, prednisone and hydrocortisone retention enemata in the out-patient treatment of left-sided colitis. Preliminary report.

Authors: J E LENNARD-JONES; A J LONGMORE; F A JONES
Journal: Proc R Soc Med Date: 1960-08

5. The treatment of ulcerative colitis.

Authors: N SVARTZ
Journal: Gastroenterologia Date: 1956

6. CHRONIC ULCERATIVE COLITIS: A SUMMARY OF EVIDENCE IMPLICATING BACTERIUM NECROPHORUM AS AN ETIOLOGIC AGENT.

Authors: L R Dragstedt; G M Dack; J B Kirsner
Journal: Ann Surg Date: 1941-10 Impact factor: 12.969

7. Bacillary Dysentery and Chronic Ulcerative Colitis in World War II.

Authors: J Felsen; W Wolarsky
Journal: Science Date: 1947-02-21 Impact factor: 47.728

8. Normal intestinal bacteria in ulcerative colitis.

Authors: H SENECA; E HENDERSON
Journal: Gastroenterology Date: 1950-05 Impact factor: 22.682

9. Autoantibody production in rabbits. VII. Autoantibodies to gut produced by the injection of bacteria.

Authors: G L Asherson; E J Holborow
Journal: Immunology Date: 1966-02 Impact factor: 7.397

10. A quantitative comparison of the faecal flora of patients with ulcerative colitis and that of normal persons.

Authors: E M Cooke
Journal: J Pathol Bacteriol Date: 1967-10

11 in total

1. Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part 1.

Authors:
Journal: Am J Dig Dis Date: 1975-06

2. Salicylazosulfapyridine in inflammatory bowel disease.

Authors: K M Das; I Sternlieb
Journal: Am J Dig Dis Date: 1975-10

Review 3. Inflammatory bowel disease as a model for translating the microbiome.

Authors: Curtis Huttenhower; Aleksandar D Kostic; Ramnik J Xavier
Journal: Immunity Date: 2014-06-19 Impact factor: 31.745

4. Clinical and radiologic improvement of regional enteritis and enterocolitis after treatment with salicylazosulfapyridine.

Authors: F Goldstein; M G Murdock
Journal: Am J Dig Dis Date: 1971-05

5. Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.

Authors: B West; R Lendrum; M J Hill; G Walker
Journal: Gut Date: 1974-12 Impact factor: 23.059

6. Effects of sulfasalazine on selected lymphocyte subpopulations in vivo and in vitro.

Authors: W R Thayer; C Charland; C E Field
Journal: Dig Dis Sci Date: 1979-09 Impact factor: 3.199

Review 7. Clinical pharmacokinetics of sulphasalazine.

Authors: K M Das; R Dubin
Journal: Clin Pharmacokinet Date: 1976 Nov-Dec Impact factor: 6.447

8. Clostridium difficile and inflammatory bowel disease.

Authors: C Greenfield; J R Aguilar Ramirez; R E Pounder; T Williams; M Danvers; S R Marper; P Noone
Journal: Gut Date: 1983-08 Impact factor: 23.059

9. Modulation of Gut Microbiome Composition and Function in Experimental Colitis Treated with Sulfasalazine.

Authors: Haihui Zheng; Mingyi Chen; Yuan Li; Yuanyuan Wang; Lin Wei; Ziqiong Liao; Mengxia Wang; Fangli Ma; Qiongfeng Liao; Zhiyong Xie
Journal: Front Microbiol Date: 2017-09-07 Impact factor: 5.640

Review 10. Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection.

Authors: Ludovica F Buttó; Monika Schaubeck; Dirk Haller
Journal: Front Immunol Date: 2015-11-19 Impact factor: 7.561